Shohei Tanaka
Musashino, 1808610, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.
Journal: Nutrients
Published: April 01, 2026
Association Between Early and Long-Term Changes in Liver Stiffness in Patients with MASLD Undergoing Serial Magnetic Resonance Elastography.
Journal: Diagnostics (Basel, Switzerland)
Published: March 30, 2026
Lactulose and rifaximin combination therapy as first-line treatment for preventing recurrent overt hepatic encephalopathy: a retrospective observational study.
Journal: European journal of gastroenterology & hepatology
Published: November 17, 2025
Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative Colitis.
Journal: Inflammatory intestinal diseases
Published: November 11, 2025
Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific Thresholds.
Journal: Journal of clinical medicine
Published: October 07, 2025
Effects of proximal tubule-specific ATRAP enhancement on hypertension in a remnant kidney chronic kidney disease model of mice.
Journal: Scientific reports
Published: October 31, 2024
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 27, 2023
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: October 17, 2023
miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap.
Journal: The Journal of biological chemistry
Published: October 16, 2023
Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Journal of gastroenterology and hepatology
Published: October 10, 2023
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: October 01, 2023
Last Updated: 09/26/2026